TGFB1 and neoplasm: Interestingly, when we measured the total uptake of the nanoparticles within the tumor, the combined DC101 and anti‐TGFβ1 antibody treatment did not result in an increase in the unit accumulation of nanoparticles as compared to DC101 treatment alone (Figure S5, Supporting Information).